(Q40417751)

English

A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer

scientific article

Statements

A dose-escalation study of recombinant human interleukin-18 using two different schedules of administration in patients with cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit